Moneycontrol
Get App
SENSEX NIFTY
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Feb 20, 16:00
599.55 -2.70 (-0.45%)
Volume
AVERAGE VOLUME
5-Day
374,895
10-Day
331,082
30-Day
199,928
433,032
  • Prev. Close

    602.25

  • Open Price

    610.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 20, 15:58
599.75 -2.10 (-0.35%)
Volume
AVERAGE VOLUME
5-Day
9,176,008
10-Day
8,096,862
30-Day
5,101,319
14,551,958
  • Prev. Close

    601.85

  • Open Price

    612.05

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    599.75 (7329)

Financials

2019 2018 2017 2016 2015
Profit & Loss account of Aurobindo Pharma (in Rs. Cr.) Mar 19 Mar 18 Mar 17 Mar 16 Mar 15  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 19,225.93 16,232.87 14,844.79 13,709.74 12,195.24  
Less: Excise/Sevice Tax/Other Levies 0.00 36.80 180.32 160.57 152.01  
Revenue From Operations [Net] 19,225.93 16,196.07 14,664.47 13,549.17 12,043.23  
Total Operating Revenues 19,563.55 16,463.03 14,909.54 13,794.65 12,120.52  
Other Income 155.32 101.98 115.89 203.80 96.71  
Total Revenue 19,718.87 16,565.01 15,025.43 13,998.45 12,217.23  
EXPENSES  
Cost Of Materials Consumed 7,444.99 5,629.38 5,184.92 4,825.56 4,122.81  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Employee Benefit Expenses 2,584.87 2,130.84 1,767.76 1,542.62 1,302.26  
Finance Costs 262.60 77.72 66.72 256.70 159.87  
Depreciation And Amortisation Expenses 667.95 557.97 427.63 392.37 332.61  
Other Expenses 4,314.10 3,810.84 3,273.24 2,901.81 2,749.04  
Total Expenses 16,542.16 13,326.97 11,969.61 11,255.60 10,049.38  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 3,176.71 3,238.04 3,055.82 2,742.85 2,167.85  
Exceptional Items -88.06 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 3,088.65 3,238.04 3,055.82 2,742.85 2,167.85  
Tax Expenses-Continued Operations  
Current Tax 712.07 712.30 691.70 710.65 596.53  
Less: MAT Credit Entitlement 51.00 43.32 64.28 0.00 9.95  
Deferred Tax 65.78 149.29 132.23 10.06 -4.22  
Other Direct Taxes 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 726.85 818.27 759.65 720.71 596.59  
Profit/Loss After Tax And Before ExtraOrdinary Items 2,361.80 2,419.77 2,296.17 2,022.14 1,571.26  
Profit/Loss From Continuing Operations 2,361.80 2,419.77 2,296.17 2,022.14 1,571.26  
Profit/Loss For The Period 2,361.80 2,419.77 2,296.17 2,022.14 1,571.26  
Minority Interest 0.23 0.26 0.47 1.50 4.51  
Consolidated Profit/Loss After MI And Associates 2,364.73 2,423.17 2,301.66 2,025.09 1,575.77  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 40.00 41.00 39.00 35.00 54.00  
Diluted EPS (Rs.) 40.00 41.00 39.00 35.00 54.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 146.48 219.71 114.11 134.37 131.28  
Tax On Dividend 13.86 44.73 23.23 27.36 25.04  
Source : Dion Global Solutions Limited